We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Arterial Stiffness and Calcifications in Incident Renal Transplant Recipients (ASCIT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00547040
Recruitment Status : Unknown
Verified October 2011 by Kathleen Claes, Universitaire Ziekenhuizen Leuven.
Recruitment status was:  Recruiting
First Posted : October 19, 2007
Last Update Posted : October 6, 2011
Information provided by (Responsible Party):
Kathleen Claes, Universitaire Ziekenhuizen Leuven

Brief Summary:

The purpose of this study is to determine the:

  • Natural history of calcification posttransplantation
  • Natural history of BMC following renal transplantation
  • Reverse correlation between calcification score and aortic calcifications following renal transplantation
  • Correlation of IMT, BMC, PWV and biochemical variables
  • Correlation of IMT, BMC, PWV, biochemical variables and outcome
  • Predictors of CV disease after transplantation
  • Predictors of IMT progression, BMC loss and PWV progression after renal transplantation

Condition or disease Intervention/treatment
Renal Transplant Atherosclerosis Arterial Stiffness Other: no intervention

Study Type : Observational
Estimated Enrollment : 100 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Arterial Stiffness and Calcifications in Incident Renal Transplant Recipients
Study Start Date : October 2006
Estimated Study Completion Date : October 2013

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Group/Cohort Intervention/treatment
incident renal transplant patients
Other: no intervention
no intervention

Primary Outcome Measures :
  1. cardiovascular outcome [ Time Frame: 5 years ]

Biospecimen Retention:   Samples Without DNA
serum, plasma, urine

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years to 90 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
incident renal transplant recipients

Inclusion Criteria:

  • Incident renal transplant patients or combined renal/pancreas transplant patients

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00547040

Contact: kathleen Claes, MD 0032/16344580 kathleen.claes@uz.kuleuven.ac.be

UZ Gasthuisberg Recruiting
Leuven, Belgium, 3000
Sponsors and Collaborators
Universitaire Ziekenhuizen Leuven
Principal Investigator: kathleen Claes, MD UZ Leuven

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Kathleen Claes, md, Universitaire Ziekenhuizen Leuven
ClinicalTrials.gov Identifier: NCT00547040     History of Changes
Other Study ID Numbers: ML3775
First Posted: October 19, 2007    Key Record Dates
Last Update Posted: October 6, 2011
Last Verified: October 2011

Keywords provided by Kathleen Claes, Universitaire Ziekenhuizen Leuven:
bone lesions

Additional relevant MeSH terms:
Arterial Occlusive Diseases
Vascular Diseases
Cardiovascular Diseases
Calcium Metabolism Disorders
Metabolic Diseases